
Leyden Labs, based at Leiden Bio Science Park, has raised $70 million to develop a new way to fight respiratory viruses.

Leyden Labs, based at Leiden Bio Science Park, has raised $70 million to develop a new way to fight respiratory viruses.

Alesta Therapeutics, a biotechnology company focused on developing transformative small molecule therapies for rare diseases, today announced the closing of an oversubscribed €65 million Series A financing round.

We’re proud to celebrate two incredible achievements from the unlock_ Incubation program.

How does collaboration work at different scales: provincial (e.g., EBZ and the province), regional (e.g., Holland Rijnland), and cluster-specific (e.g., Leiden Bio Science Park)? These interconnected levels play a vital role in building a stronger South Holland. In this podcast,…

Leiden Bio Science Park hosted a Swiss delegation, showcasing innovations in health and life sciences.
The LBSP the privacy of all her relations and users of the website www.leidenbiosciencepark.nl

[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_text admin_label=”Text” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}” theme_builder_area=”post_content”] The labor market in the Netherlands is under significant strain, and healthcare is one…

After several years of absence, TW, in collaboration with TNO Vector and VNO-NCW, has reintroduced the R&D Top 30, a well-regarded list highlighting corporate R&D expenditures in the Netherlands. This ranking has offered a clear picture of where companies have…

Campuses and science parks are a driving force for the national economy, accelerating innovation and contributing to solutions for the challenges we face as a society.

Leiden University leased land to Janssen Biologics for a new facility at the Bio Science Park, expanding with more labs and offices.

Knowledge City Leiden urged the government to rethink education cuts.

We’re proud to celebrate the success of VitroScan, one of the innovative biotech companies based here at Leiden Bio Science Park, as it secures €1.9 million from Biotech Booster to advance its ChemoPredict™ platform.